InsiderPresident & Immunovant CEO

Eric Venker Insider Trading Activity

Every SEC Form 4 transaction reported by Eric Venker, sourced directly from SEC EDGAR and updated as new filings are accepted.

By · SEC Form 4 & insider trading data analysts
Last updated:

Quick Answer

Is Eric Venker buying or selling?

Eric Venker reported 0 open-market buys ($0) and 56 sells ($194.4M) across 56 Form 4 filings at 2 companies — a net selling position of $194.4M.

Source: SEC EDGAR Form 4

Key Statistics (as of Sep 2, 2026)

Total Form 4 filings
56
SEC EDGAR
Companies
2
Buys (0)
$0
Sells (56)
$194.4M

Insider sentiment

Net selling

Net insider flow of $194.4M in net selling, filed between Mar 29, 2022 – Sep 2, 2026.

Companies Eric Venker files for

#CompanyForm 4 filings
1ROIVRoivant Sciences Ltd.54
2IMVTImmunovant, Inc.2

Recent Eric Venker transactions

DateTickerRoleTypeSharesValue
Sep 2, 2026ROIVPresident & Immunovant CEOSale200.0K$7.2M
Jul 30, 2026ROIVPresident & Immunovant CEOSale200.0K$7.0M
Jul 6, 2026IMVTChief Executive OfficerSale3.1K$119.0K
Jun 26, 2026ROIVPresident & Immunovant CEOSale200.0K$6.6M
May 22, 2026ROIVPresident & Immunovant CEOSale200.0K$6.1M
Apr 22, 2026ROIVPresident & Immunovant CEOSale200.0K$5.9M
Apr 3, 2026IMVTChief Executive OfficerSale14.2K$342.9K
Mar 19, 2026ROIVPresident & Immunovant CEOSale200.0K$5.6M
Feb 18, 2026ROIVPresident & Immunovant CEOSale200.0K$5.3M
Jan 15, 2026ROIVPresident & Immunovant CEOSale200.0K$4.4M
Dec 30, 2025ROIVPresident & Immunovant CEOSale275.0K$6.2M
Dec 12, 2025ROIVPresident & Immunovant CEOSale200.0K$4.2M
Oct 18, 2025ROIVPresident & Immunovant CEOSale851.4K$14.5M
Oct 15, 2025ROIVPresident & Immunovant CEOSale125.7K$2.0M
Oct 9, 2025ROIVPresident & Immunovant CEOSale665.2K$10.8M
Sep 24, 2025ROIVPresident & Immunovant CEOSale1.7M$25.5M
Aug 23, 2025ROIVPresident & Immunovant CEOSale100.0K$1.2M
Jul 24, 2025ROIVPresident & Immunovant CEOSale100.0K$1.2M
Jun 25, 2025ROIVPresident & COOSale100.0K$1.1M
Jun 5, 2025ROIVPresident & COOSale1.0M$11.2M
May 23, 2025ROIVPresident & COOSale100.0K$1.1M
Apr 23, 2025ROIVPresident & COOSale100.0K$1.0M
Mar 25, 2025ROIVPresident & COOSale750.0K$8.2M
Feb 25, 2025ROIVPresident & COOSale100.0K$1.1M
Feb 15, 2025ROIVPresident & COOSale435.4K$4.6M

Showing the 25 most recent filings of 56. Screen every filing.

Eric Venker insider trading FAQ

Is Eric Venker buying or selling?

Across 56 SEC Form 4 filings, Eric Venker reported 0 open-market purchases totaling $0 and 56 sales totaling $194.4M — a net selling position of $194.4M.

Which companies does Eric Venker file Form 4s for?

Eric Venker has reported insider transactions at 2 companies, most often Roivant Sciences Ltd. (ROIV), Immunovant, Inc. (IMVT).

How far back does Eric Venker's filing history go?

Trabud holds Eric Venker's SEC Form 4 filings from Mar 29, 2022 – Sep 2, 2026, sourced directly from SEC EDGAR.

Where does Trabud get Eric Venker's insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Learn

What is SEC Form 4?

The filing behind every transaction here

Guide

How to Track Insider Trading

A practical workflow for following Form 4 activity

Use Case

Insider Buying Signals

How investors read insider purchases

Track Eric Venker and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener